ASTRAZENECA is taking a huge stake in the start-up behind Imperial College London's experimental COVID-19 vaccine in the hope of creating new groundbreaking treatment.
Friday, 24 September 2021
AstraZeneca secures huge deal with UK start-up to produce new groundbreaking vaccine
ASTRAZENECA is taking a huge stake in the start-up behind Imperial College London's experimental COVID-19 vaccine in the hope of creating new groundbreaking treatment.
0 comments:
Post a Comment